Rapid weight gain and benign intracranial hypertension in an AIDS patient on treatment with highly active anti-retroviral therapy (HAART)

West Indian Medical Journal

Volumn 49, Issue 4, 2000, Pages 338-339

  Lisk, D R ^a   Cummings, C C ^a   Charles, C C ^a   Foley, E ^a   Ujah, U ^a  

^a George Town Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BODY FAT; CASE REPORT; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACRANIAL HYPERTENSION; LYMPHOCYTE COUNT; OPPORTUNISTIC INFECTION; VIRUS LOAD; WEIGHT GAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; PSEUDOTUMOR CEREBRI; WEIGHT GAIN;

EID: 0034486127     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Griffin JP. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug React Toxicol. Rev 1992; 11: 41-57.
2. Price RW. Neurological complications of HIV infection. Lancet 1996; 348: 445-52.
3. Gross FJ, Mindel JS. Pseudotumor cerebri and Guillain-Barré syndrome associated with human immunodeficiency virus infection. Neurology 1991; 41: 1847-8.
4. Traverso F, Stagnaro R, Fazio B. Benign intracranial hypertension associated with HIV infection. Eur Neurol 1993; 33: 191-2.
5. Schwarz S, Husstedt IW, Georgiadis D. Benign intracranial hypertension in an HIV-infected patient: headache as the only presenting sign. AIDS 1995; 9: 657-8.
6. Heudier P, Chichmanian RM, Taillan B, Gratecos N, Fuzibet JG, Dujardin P. Hypertension intracranienne bénigne médicamenteuse: à propos d'un cas rapporté à l'amphotericine B. Revue de la littérature. Thérapie 1992; 47: 403-7.
7. Editorial. Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet 1998; 351: 228-30.
8. Silva M, Skolnik PR, Gorbach SL, Spiegelman D, Wilson IB, Fernandez-DiFranco MG, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998; 12: 1645-51.
9. Stricker RB, Goldberg B. Weight gain associated with protease inhibitor therapy in HIV-infected patients. Res Virol 1998; 149: 123-6
10. Stricker RB, Conlin D, Marx M, Wiviott L. Localized adipose tissue hypertrophy in patients receiving human immunodeficiency virus protease inhibitors. Clin Infect Disease 1998; 27: 218-20.
11. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet 1998; 351: 867-70.
12. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998; 351: 871-5
13. Yarasheski KE, Zachwieja JJ, Horgan MM, Powderly WG, Santiago JV, Landt M. Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. Metabolism 1997; 46: 303-5.